Improving Venous Thromboembolism Prophylaxis

Completed · Phase 4

Conditions studied: Venous Thromboembolism, Delivery of Health Care, Quality Improvement

In brief

Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for \"spreading\" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.

Key facts

Study ID

NCT01304108

Run by

Mayo Clinic

People needed

3000

Starts

2009-01-01

Expected to finish

2010-05-01

Last updated by the study team

2011-02-25

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Inpatients with age > 17 years old

You may not qualify if…

• Outpatients
• Inpatients with age less than or equal to 17 years old

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.